Stay updated on Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations section updated to add new study sites across the United States, Australia, Canada, and several European regions, and older location entries were removed. The revision also includes a new version tag (v3.3.3).
    Difference
    1%
    Check dated 2025-12-23T13:31:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not relate to the study; updated the page revision to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:53:12.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice that warned information may be out of date and directed users to operating-status pages. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:44:45.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Minor updates on the Study Details page, including the latest update timestamp and a new publication reference. No changes to study design, eligibility criteria, endpoints, or patient-facing information.
    Difference
    0.3%
    Check dated 2025-11-03T12:33:11.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and an updated version tag (v3.2.0) while removing the old version tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T16:43:18.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and adds information about B-cell lymphoma; previous version tag v3.0.2 is removed.
    Difference
    0.1%
    Check dated 2025-09-28T09:52:12.000Z thumbnail image

Stay in the know with updates to Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.